Vesicular Monoamine Transporter Type 2 (VMAT2) Inhibitors in the Management of Tardive Dyskinesia

Journal Title: Clinical Medical Reviews and Case Reports - Year 2017, Vol 4, Issue 12

Abstract

Neuroleptic medications are prescribed for the management of mental, gastrointestinal, and neurological disorders. These disorders occur via over-excitation of dopamine in the brain. When neuroleptics are used, dopamine receptors are blocked reducing the excitation. Thus, the disorder becomes controlled. The long-term use of neuroleptics can result in a misfire of the neurons of the brain causing tardive dyskinesia (TD), an irreversible chronic condition of spontaneous movements.

Authors and Affiliations

Keywords

Related Articles

Brief Comment on the Challenge and Opportunities for Effective Containment of the Type 2 Diabetes Mellitus Epidemic that Affects the World Population

It is a chronic disease associated with multiple health problems: Cardio-cerebrovascular, cancer, behavioral disorders, depression or anxiety, localized or generalized neuropathy problems due to irritation or destruction...

Tetanus: A Case Report following an Upper Extremity Injury

Clostridium tetani is a spore-forming, toxin-producing, anaerobic, gram-positive bacillus which enters the CNS causing painful muscle contractions within the host. These painful spasms and stiffness typically manifest in...

Continuous Bilateral Brachial Plexus Blockade for Acute Pain Control in Patients with Bilateral Upper Extremity Traumatic Injuries: A Review of Five Cases

In this study we discuss five case scenarios where we felt bilateral brachial plexus blocks were appropriate and, if performed with caution, the benefits would outweigh the risks. Each of these patients suffered severe b...

A Case of Refractory Dysphagia in the Context of Polymyositis Treated with Subcutaneous Immunoglobulin and Review of the Literature

Polymyositis (PM) is a systemic inflammatory disease affecting muscles and several other organs, including gastrointestinal system, in which the main symptom is dysphagia.

Prevention, Detection and Diagnosis of Expressive Oral Language Disorders in Premature Infants

To prevent language disorders in a vulnerable population we must understand that the language development is a multisensory and above-modal integration with specific neurodevelopmental period, some of which remain to stu...

Download PDF file
  • EP ID EP272568
  • DOI 10.23937/2378-3656/1410198
  • Views 99
  • Downloads 0

How To Cite

(2017). Vesicular Monoamine Transporter Type 2 (VMAT2) Inhibitors in the Management of Tardive Dyskinesia. Clinical Medical Reviews and Case Reports, 4(12), 1-5. https://europub.co.uk/articles/-A-272568